Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry).

MLA

Solans, Laqué, Roser, et al. “Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry).” Arthritis Care & Research, vol. 72, no. 7, July 2020, pp. 1001–10. EBSCOhost, https://doi.org/10.1002/acr.23912.

APA

Solans, L. R., Rodriguez, C. M., Rios, B. J. J., Fraile, G., Sáez, C. L., Martinez, Z. A., Frutos, B., Solanich, X., Fonseca, A. E., Pasquau, L. F., Zamora, M., Oristrell, J., Fanlo, P., Lopez, D. M., Abdilla, M., García, S. I., Sopeña, B., Castillo, M. J., Perales, I., & Callejas, J. L. (2020). Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry). Arthritis Care & Research, 72(7), 1001–1010. https://doi.org/10.1002/acr.23912

Chicago

Solans, Laqué, Roser, Carballeira, Monica Rodriguez, Blanco, Juan Jose Rios, Guadalupe Fraile, Comet, Luis Sáez, Zapico, Aleida Martinez, Begoña Frutos, et al. 2020. “Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry).” Arthritis Care & Research 72 (7): 1001–10. doi:10.1002/acr.23912.